6 news items
ICON plc to hold Investor Day Meeting on May 30, 2024
ICLR
20 May 24
, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve
ICON releases its ICON Cares 2023 Report
ICLR
9 May 24
In 2023, the company leveraged technology, data and partnerships to increase patient access to clinical trials and drive innovation. Examples include
ICON Announces Pricing of USD 2 Billion Notes
ICLR
30 Apr 24
and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin
ICON Reports First Quarter 2024 Results
ICLR
24 Apr 24
, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve
ICON Announces CFO Transition
ICLR
3 Apr 24
health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland
tzs2pk rxba
ICLR
25 Mar 24
services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging
- Prev
- 1
- Next